Answers are grounded in this paper and cite their sources.
Definition of Syndrome: The diagnosis of the antiphospholipid antibody syndrome, also known as lupus anticoagulant syndrome or Hughes’ syndrome, requires both clinical events and unequivocal demonstration of antiphospholipid antibody by either enzyme-linked immunoadsorbent assay (ELISA) or a coagulation test positive for lupus anticoagulant (LAC). The antibody alone, in the absence of clinical symptoms, does not suffice for a diagnosis. Nonpathogenic antiphospholipid antibody, but not the syndrome, can be induced by drugs1 or by infections.2 Antiphospholipid antibody syndrome occurs in patients with no other diagnosis (primary antiphospholipid antibody syndrome, PAPS) and with systemic lupus erythematosus or other rheumatic disease (secondary APS). Preliminary criteria for the classification of the antiphospholipid antibody syndrome are listed in Table 1.3 These are classification criteria to be used to compare patient groups. Guidelines are useful for evaluating common manifestations and are not meant to be used in the diagnosis of individual patients. Other, less typical clinical and laboratory abnormalities may justify the diagnosis (Table 2). There are no age limits to the diagnosis and no specified interval between clinical event and demonstration of autoantibody, but symptoms and abnormal serology are usually simultaneously present.
No takes yet. Share an insight, caveat, or question.
Michael D. Lockshin (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: